RxDoctor Payments Data

David Wright, MD

MOHS-Micrographic Surgery · Irving, TXNPI 1689917007

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Kerecis Limited at 41.7% of the total. Reporting peaked in 2019 at $785 and has fallen 54.6% since, to $357 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in TX, where the typical reported total is $1,382.

$1,885in general payments, 2019–2025

Across 31 payments — averaging $60.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$787
  • AbbVie$262
  • Keswick Pharmaceuticals LLC$246
  • Convatec Inc.$167
  • Genentech USA, Inc.$121
  • Lilly USA, LLC$100
  • plus $203 from 4 others

What the payments were for

  • Food & beverage$1,885100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Kerecis Limited14$787
AbbVie3$262
Keswick Pharmaceuticals LLC1$246
Convatec Inc.5$167
Genentech USA, Inc.1$121
Lilly USA, LLC1$100
Galderma Laboratories, L.p.2$81
Progenacare Global, LLC1$51
Regeneron Healthcare Solutions, Inc.2$44
Organogenesis Inc.1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,885 in reported general payments places this provider in the 50th percentile of 109 mohs-micrographic surgery providers in Texas.

See all mohs-micrographic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$872,809
Medicare patients
574
Services billed
2,175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate275$2,131
Fluorouracil20$1,197
Cephalexin11$47

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Irving

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →